{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:03:16Z","timestamp":1783605796540,"version":"3.55.0"},"reference-count":57,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Friends of Prentice Grants Initiative, the U.S. Department of Veterans Affairs","award":["BX006012"],"award-info":[{"award-number":["BX006012"]}]},{"name":"Diana, Princess of Wales Endowed Professorship from the Lurie Cancer Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>N6-methyladenosine (m6A) has emerged as a pivotal regulator of post-transcriptional gene control, yet its contribution to chemotherapy resistance remains insufficiently defined. Here, we describe a previously unrecognized METTL3-ADAM23 epitranscriptomic regulatory relationship associated with platinum (Pt) resistance in ovarian cancer (OC). We show that cisplatin treatment increases global m6A levels and METTL3 expression, linking Pt exposure to activation of the m6A machinery. Functional perturbation studies demonstrate that METTL3 overexpression enhances cisplatin resistance, whereas METTL3 knockdown or pharmacologic inhibition with the selective METTL3 inhibitor STM2457 sensitizes OC cells to Pt treatment in vitro and improves Pt response in vivo. Transcriptomic profiling identifies ADAM23, a cell-adhesion-related tumor suppressor, as a METTL3-dependent, m6A-associated transcript, with altered mRNA expression observed across multiple experimental systems and several high-confidence predicted m6A sites within its transcript. Cisplatin-associated METTL3 upregulation correlates with reduced ADAM23 expression, suggesting a potential regulatory relationship that may contribute to chemoresistance. Together, these findings support a model in which METTL3-associated increases in m6A methylation are linked to Pt resistance, in part through modulation of ADAM23 expression, and highlight METTL3 as a potential therapeutic target in OC.<\/jats:p>","DOI":"10.3390\/cells15030294","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:51:56Z","timestamp":1770209516000},"page":"294","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epitranscriptomic Regulation of Platinum Resistance via the METTL3-ADAM23 Axis in Ovarian Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Ujin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-5035","authenticated-orcid":false,"given":"Daniela","family":"Matei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Jesse Brown VA Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-6967","authenticated-orcid":false,"given":"Hao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"ref_1","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","article-title":"OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer","volume":"30","author":"Aghajanian","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, Y., Duval, A.J., Adli, M., and Matei, D. (2024). Biology-driven therapy advances in high-grade serous ovarian cancer. J. Clin. Investig., 134.","DOI":"10.1172\/JCI174013"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2643-3249.BCD-20-0032","article-title":"Epitranscriptomics in Hematopoiesis and Hematologic Malignancies","volume":"1","author":"Ferrer","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41392-020-00300-w","article-title":"Epitranscriptomics and epiproteomics in cancer drug resistance: Therapeutic implications","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2016.07.005","article-title":"Structures of the m(6)A Methyltransferase Complex: Two Subunits with Distinct but Coordinated Roles","volume":"63","author":"Zhou","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","article-title":"YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner","volume":"138","author":"Feng","year":"2021","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41419-025-07844-1","article-title":"O-GlcNAcylation of METTL3 drives hepatocellular carcinoma progression by upregulating MCM10 expression in an m6A-IGF2BP3-dependent manner","volume":"16","author":"Chen","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/or.2023.8502","article-title":"[Corrigendum] METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression","volume":"49","author":"Zhang","year":"2023","journal-title":"Oncol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"217215","DOI":"10.1016\/j.canlet.2024.217215","article-title":"METTL3-STAT5B interaction facilitates the co-transcriptional m(6)A modification of mRNA to promote breast tumorigenesis","volume":"603","author":"Bhattarai","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2018.09.015","article-title":"METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition","volume":"151","author":"Hua","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_18","first-page":"3197","article-title":"METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway","volume":"19","author":"Liang","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41420-021-00600-2","article-title":"METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246","volume":"7","author":"Bi","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/0008-5472.CAN-08-2976","article-title":"ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis","volume":"69","author":"Verbisck","year":"2009","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/sj.onc.1207263","article-title":"Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors","volume":"23","author":"Costa","year":"2004","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/sj.onc.1208952","article-title":"ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation","volume":"24","author":"Takada","year":"2005","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1038\/sj.onc.1207783","article-title":"Identification of 27 5\u2032 CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers","volume":"23","author":"Hagihara","year":"2004","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114165","DOI":"10.1016\/j.celrep.2024.114165","article-title":"Small-molecule inhibition of the METTL3\/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation","volume":"43","author":"Pomaville","year":"2024","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2407426","DOI":"10.1002\/advs.202407426","article-title":"Chromatin Organization Governs Transcriptional Response and Plasticity of Cancer Stem Cells","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/1078-0432.CCR-23-2368","article-title":"Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer","volume":"30","author":"Wang","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"bbae237","DOI":"10.1093\/bib\/bbae237","article-title":"CPADS: A web tool for comprehensive pancancer analysis of drug sensitivity","volume":"25","author":"Li","year":"2024","journal-title":"Brief. Bioinform."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","article-title":"Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer","volume":"28","author":"Xu","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-25-0043","article-title":"Metabolic Dependency on De Novo Pyrimidine Synthesis is a Targetable Vulnerability in Platinum Resistant Ovarian Cancer","volume":"86","author":"Cardenas","year":"2025","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","article-title":"Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2305212","DOI":"10.1002\/advs.202305212","article-title":"Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41698-019-0103-4","article-title":"Interferon-gamma signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer","volume":"3","author":"Cardenas","year":"2019","journal-title":"NPJ Precis. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ajog.2004.05.025","article-title":"The epigenetics of ovarian cancer drug resistance and resensitization","volume":"191","author":"Balch","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1158\/0008-5472.CAN-17-1492","article-title":"Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs","volume":"78","author":"Fang","year":"2018","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","article-title":"14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival","volume":"69","author":"Neal","year":"2009","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gkw104","article-title":"SRAMP: Prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features","volume":"44","author":"Zhou","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/cas.13985","article-title":"A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients","volume":"110","author":"Zmetakova","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101924","DOI":"10.1016\/j.gde.2022.101924","article-title":"Cancer epitranscriptomics in a nutshell","volume":"75","author":"Primac","year":"2022","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1535-7163.MCT-22-0278","article-title":"N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase","volume":"22","author":"Huang","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41375-022-01696-w","article-title":"METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/cmdc.202100291","article-title":"METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes","volume":"16","author":"Huang","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jmedchem.2c01601","article-title":"METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey","volume":"66","author":"Fiorentino","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_48","first-page":"1500","article-title":"Effects of integrin-linked kinase on protein kinase b, glycogen synthase kinase-3beta, and beta-catenin molecules in ovarian cancer cells","volume":"24","author":"Incesu","year":"2021","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wantoch von Rekowski, K., Konig, P., Henze, S., Schlesinger, M., Zawierucha, P., Januchowski, R., and Bendas, G. (2019). The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells. Biomolecules, 9.","DOI":"10.3390\/biom9120788"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1038\/oncsis.2016.86","article-title":"Inhibition of the integrin\/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy","volume":"6","author":"Xu","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"102242","DOI":"10.1016\/j.jbc.2022.102242","article-title":"Tissue transglutaminase activates integrin-linked kinase and beta-catenin in ovarian cancer","volume":"298","author":"Condello","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/s41388-018-0297-x","article-title":"Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer","volume":"37","author":"Rada","year":"2018","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Mitra","year":"2011","journal-title":"Oncogene"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.7150\/ijms.103141","article-title":"Targeted inhibition of integrin alphaVbeta3 induces cytotoxicity and suppresses migration ability in ovarian cancer cells and tumor spheroids","volume":"22","author":"Hsin","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"45352","DOI":"10.18632\/oncotarget.9977","article-title":"PRAME expression and promoter hypomethylation in epithelial ovarian cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2013.12.031","article-title":"Inhibition of alpha4beta1 integrin increases ovarian cancer response to carboplatin","volume":"132","author":"Scalici","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13046-024-03083-y","article-title":"Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer","volume":"43","author":"Atwani","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/3\/294\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:59:23Z","timestamp":1770209963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/3\/294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cells15030294"],"URL":"https:\/\/doi.org\/10.3390\/cells15030294","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}